Chen Jing,Ma Lin,Qu Baolin,et al.Nimotuzumab and cetuximab enhanced radiation effects on human esophageal carcinoma cells[J].Chinese Journal of Radiological Medicine and Protection,2014,34(7):489-492
Nimotuzumab and cetuximab enhanced radiation effects on human esophageal carcinoma cells
Received:August 06, 2013  
DOI:10.3760/cma.j.issn.0254-5098.2014.07.003
KeyWords:Epidermal growth factor receptor  Nimotuzumab  Cetuximab  Esophageal carcinoma  Irradiation
FundProject:
Author NameAffiliationE-mail
Chen Jing PLA General Hospital Cancer Center and Department of Radiotherapy, PLA Postgraduate School of Medicine, Beijing 100853, China  
Ma Lin PLA General Hospital Cancer Center and Department of Radiotherapy, PLA Postgraduate School of Medicine, Beijing 100853, China  
Qu Baolin PLA General Hospital Cancer Center and Department of Radiotherapy, PLA Postgraduate School of Medicine, Beijing 100853, China  
Li Jianxiong PLA General Hospital Cancer Center and Department of Radiotherapy, PLA Postgraduate School of Medicine, Beijing 100853, China  
Lan Yuling PLA General Hospital Cancer Center and Department of Radiotherapy, PLA Postgraduate School of Medicine, Beijing 100853, China  
Yang Yongqiang PLA General Hospital Cancer Center and Department of Radiotherapy, PLA Postgraduate School of Medicine, Beijing 100853, China  
Meng Lingling PLA General Hospital Cancer Center and Department of Radiotherapy, PLA Postgraduate School of Medicine, Beijing 100853, China  
Feng Linchun PLA General Hospital Cancer Center and Department of Radiotherapy, PLA Postgraduate School of Medicine, Beijing 100853, China 301flc@163.com 
Hits: 5334
Download times: 2779
Abstract::
      Objective To observe the combination effects of radiation and nimotuzumab (h-R3) or cetuximab (C225) on human esophageal squamous carcinoma cell line TE-13.Methods TE-13 cells were divided into 6 groups, including no treatment control, h-R3, C225, irradiation, h-R3 combined with irradiation, and C225 combined with irradiation. For each group, cell proliferation was evaluated by MTS assay, cell radiosensitivity was determined by clonogenic assay and the survival curve was fitted with the multi-targets single-hit model, and cell cycle distribution and apoptosis were analyzed with flow cytometry assay. Results Compared with the irradiation group, after the combination treatment of mAbs and irradiation, the cell proliferation, the cell proliferations were obviously decreased (F=325.59,P<0.05), SF2, D0, Dq, and N values were obviously decreased, the cell apoptosis rates were significantly increased (F=120.59,P<0.05), and the percentages of cells in G0/G1 and G2/M phases were increased. The cell apoptosis rate of the C225 combined with irradiation group was higher than that of the h-R3 combined with irradiation group (F=120.59,P<0.05). The radiosensitization enhancement ratio (SER) of C225 was 1.83, higher than that of h-R3. Conclusions Both h-R3 and C225 can significantly enhance radiation damage of TE-13 cells and C225 is more effective than h-R3.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:11565709  On-line:0

v
Scan QR Code
&et=F5C87AEF9AD11B7C6BFE1AABAB4B54E3CE33A4BE9DE01BC74B39B27C70628F5E2983303EDFC88B2AA4A6EAB9F50D3A964C4F246D8E53A56A9BC6627B850BB63022C0CAFDE6ADEC3CD79A3E68F2DF015A8283E0D6DD379A97FD633E83F0C81DFF&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9EAD63ADE6B277ED&aid=895CE2F31BE4E942B2DE16D3F9DBE39E&vid=&iid=DF92D298D3FF1E6E&sid=F176272DD933A0BB&eid=4A2356A1257A12EB&fileno=20140703&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9EAD63ADE6B277ED"; var my_aid="895CE2F31BE4E942B2DE16D3F9DBE39E";